Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
90 hedge funds and large institutions have $283M invested in Taro Pharmaceutical Industries Ltd. in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 31 reducing their positions, and 16 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 94 → 90 (-4)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
23% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 31
26% less capital invested
Capital invested by funds: $384M → $283M (-$101M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $983K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$13.1M |
| 2 |
KAM
Krensavage Asset Management
New York
|
+$10.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10M |
| 4 |
EP
Eversept Partners
New York
|
+$5.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$7.66M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.81M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
-$5.49M |
| 4 |
Millennium Management
New York
|
-$4.38M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.74M |
TARO Hedge Fund Activity: Q1 2020 in Review
90 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2020, worth a combined $283M — down 26% from $384M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of TARO and 14 opened new positions — a net loss of 2 holders — while 31 trimmed existing stakes and 24 added.
The largest buyer was Brandes Investment Partners, adding an estimated $13.1M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $7.66M sold.
- 90 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2020, down from 94 in Q4 2019.
- Funds reported $283M of Taro Pharmaceutical Industries Ltd. stock for Q1 2020, down 26% quarter-over-quarter.
- 14 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2020 and 16 closed out, a net change of -2 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2020 was Brandes Investment Partners, an estimated $13.1M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2020 was OMERS Administration Corp, an estimated $7.66M sold.
Based on aggregated 13F filings for Q1 2020.